Core Viewpoint - The company has approved the use of idle self-owned funds to invest in low-risk financial products and government bond reverse repos, with a maximum amount of RMB 50 million, to enhance the efficiency of fund utilization and create greater value for the company and its shareholders [3][10][19]. Group 1: Board Meeting Details - The 13th meeting of the 7th Board of Directors was held on December 28, 2025, with all 9 directors present, and was conducted in compliance with relevant laws and regulations [2][4]. - The meeting was chaired by Chairman Tao Xucheng and included senior management in attendance [2]. Group 2: Investment Proposal - The board approved the proposal to use idle self-owned funds for purchasing financial products and engaging in government bond reverse repos, with a total investment limit of RMB 50 million [3][10]. - The investment aims to improve the efficiency of idle funds while ensuring the company's operational and project investment needs are met [10][19]. Group 3: Investment Details - The investment will focus on low-risk financial products issued by banks or securities companies rated A or above by the China Securities Regulatory Commission, with a maturity of no more than 12 months [9][12]. - The authorized investment period is valid for 12 months from the date of board approval [13]. Group 4: Financial Management - The funds for this investment will come from the company's idle self-owned funds and will not involve raised funds or bank credit [14]. - The company will maintain a strict evaluation process for the financial products to mitigate risks associated with market fluctuations [16]. Group 5: Impact on Company Operations - The investment in financial products and government bond reverse repos will not adversely affect the company's daily operations or project investments, and is expected to enhance the efficiency of idle fund utilization [19].
山东宝莫生物化工股份有限公司第七届董事会第十三次会议决议公告